Pfizer chooses Lorch as new chairman
This article was originally published in Scrip
Pfizer's board has elected George Lorch, who has served as an independent director since 2000, as its new non-executive chairman. To focus on his new role, Mr Lorch has stepped down from both the company's compensation and science & technology committees. The Pfizer board elected James Kilts as chairman of its compensation committee.